Investment Summary |
|
|---|---|
| Date | 2004-12-06 |
| Target | SemBioSys Genetics |
| Sector | Consumer Products |
| Sellers(s) | Bay City Capital |
| Deal Type | IPO |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Venture Capital Firm |
|---|---|
| Founded | 1997 |
| PE ASSETS | 1.3B USD |
| Size | Large |
| Type | Sector Focused |
Bay City Capital LLC was established in 1997 as an equal partnership between The Craves Group and certain Pritzker family business interests for the purpose of managing investment funds in the life sciences industry. Bay City looks for opportunities at all stages of development in biopharmaceuticals, drug discovery, medical devices and diagnostics. Bay City Capital is based in San Francisco, California.
| DEAL STATS | # |
|---|---|
| Overall | 15 of 62 |
| Sector (Consumer Products) | 1 of 2 |
| Type (IPO) | 9 of 23 |
| State (Alberta) | 1 of 1 |
| Country (Canada) | 1 of 1 |
| Year (2004) | 3 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2004-10-20 |
VNUS Medical Technologies
San Jose, California, United States VNUS Medical Technologies, Inc. is a provider of medical devices for the minimally invasive treatment of venous reflux. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2004-12-17 |
Epoch Biosciences
Bothell, Washington, United States Epoch Biosciences, Inc. is a biotech company focused on development and commercialization of proprietary nucleic acid chemistries for research and diagnostic applications. |
Sell | - |
